A Science Immunology study shows how sequential CD40L, IL-4, and IL-21 signaling generates human germinal center B-like cells in vitro—and what the iGCB platform can and cannot model.

Are three batches enough? Explore the process validation lifecycle, PPQ evidence, and continued monitoring through a hypothetical monoclonal antibody program.

Can semaglutide do more than reduce weight? This article examines new mouse evidence linking GLP-1 signaling, calorie restriction, aging biology and healthspan—and what it could mean for human translation and drug development.

Biologics processes continue to evolve after approval. This guide explains how ICH Q12 uses Established Conditions, PACMPs, PLCM documents, and the PQS to make post-approval CMC changes more predictable and risk-based.

A 2026 Science study uses CRISPR TAPIR to increase rRNA transcription and asks whether translation capacity itself can shape stem cell fate, linking ribosome biology with regeneration, ribosomopathies, and cancer.

Biologics quality cannot rely on release testing alone. This guide explains how to build an integrated strategy across materials, manufacturing, analytics, specifications, and continued monitoring.

A practical, end-to-end guide to mRNA-LNP CMC—from templates, IVT mRNA, lipid raw materials, and scale-up to potency, stability, comparability, and current global regulatory expectations.

The bottleneck in In Vivo CAR T may be delivery rather than the CAR itself. This article examines ERTLNP, T-cell activation, mTOR signaling, CMC implications, and the emerging 2026 clinical landscape.

Passing release specifications does not establish comparability. Learn how ICH Q5E integrates risk assessment, analytical characterization, stability, process data, and regulatory strategy.

A biologics specification is not simply a table of tests and limits. This guide explains how ICH Q6B connects product characterization, critical quality attributes, release testing, acceptance criteria, CTD Module 3, and the evolving direction of Q6(R1).

Four ISSCR 2026 keynotes point to one conclusion: gene delivery is the real bottleneck in cell and gene therapy. What it means for CMC, CDMOs, and capital.

Biologics CMC Regulatory Framework: Executive Summary If you only have three minutes, remember these five points: Biologics CMC is not a single regulation. It is a lifecycle framework connecting the product, manufacturing process, analytical methods, control strategy, and pharmaceutical quality system. ICH provides a shared scientific language. FDA and European authorities apply those principles through their own laws, submission pathways, and post-approval change procedures.

Many people are surprised when they first read one of the most famous lines in the Tao Te Ching: “Heaven and Earth are not benevolent; they treat all things as straw dogs.” At first glance, this passage sounds cold—even cruel. It may seem as if Lao Tzu is saying that nature is indifferent to life and that human beings have little value. However, Tao Te Ching Chapter 5 is actually one of the most misunderstood chapters in the entire book. Lao Tzu is not advocating cruelty. He

Original Text The Tao is like an empty vessel;
Though used, it is never filled.
It is profound, the source of all things.
It blunts sharpness, untangles knots, softens brilliance, and becomes one with the dust.
It seems hidden, yet it always exists.
I do not know whose child it is;
It appears to have existed before Heaven itself. Tao Te Ching Chapter 4: Plain Language Explanation and Core Message Tao Te Ching Chapter 4 reminds us that true strength does not come from possessi

Executive Summary If you only have three minutes to read this article, here are five key takeaways: Aging is increasingly viewed as a biological process that can potentially be modified, rather than an inevitable consequence of time. The discovery of the Yamanaka Factors revolutionized modern biology by demonstrating that cell identity is reversible, leading to the development of induced pluripotent stem cells (iPSCs). Today, the most exciting direction in aging research is P

Executive Summary If you only have three minutes to read this article, I hope you'll remember these six things first. The real challenge of Gene Therapy is not just finding the therapeutic gene, but how to safely and effectively deliver the gene into the right cells. AAV (Adeno-associated virus) is one of the most mature in vivo gene delivery platforms currently available. Researchers remove most of the virus's genes, retaining only the structures needed for delivery, and the

學士、碩士、博士不是越高越好，而是要看你想用學位換到什麼職涯選擇權。這篇用 2026 年職場現實、研究訓練、biotech 與跨領域案例，幫你判斷該直接工作、念碩士，還是投入博士。

Figure 1. Evolution from autologous to off-the-shelf cell therapy. Comparison of autologous and allogeneic cell therapy manufacturing workflows. Unlike patient-specific manufacturing, iPSC-derived allogeneic therapies leverage Master Cell Banks (MCBs), standardized manufacturing processes, and large-scale production to enable scalable, off-the-shelf regenerative medicine. Executive Summary Key Takeaways Induced pluripotent stem cells (iPSCs) have evolved from a stem cell tech

Figure 1. The Journey of Induced Pluripotent Stem Cells (iPSCs): From Somatic Cell Reprogramming to Regenerative Medicine. Adult somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs), expanded and banked, differentiated into specialized cell types, and applied in disease modeling, drug discovery, regenerative medicine, and cell therapy. This workflow highlights how iPSCs serve as a foundational platform technology connecting basic research with transla

Introduction: The Biggest Exam After Graduation Is Finding a Job For many students, graduation marks the beginning of a new chapter in life. However, beyond finishing a thesis or passing the final exam, one of the most stressful challenges is often finding a job. Many students experience the same questions when they first enter the job market: What kind of job is right for me? Is my resume strong enough? Why am I not hearing back after submitting applications? How should I pr